InvestorsHub Logo
Followers 43
Posts 10679
Boards Moderated 0
Alias Born 07/15/2007

Re: None

Monday, 07/29/2013 6:05:15 PM

Monday, July 29, 2013 6:05:15 PM

Post# of 146240
NNVC:

From Dr Seymour:

Primates


We have no plans to do any primate work


We've developed a small animal model for MERS and will use that


Working on all of the pre-tox studies necessary to start the tox program


You will hear more about those studies shortly


Once they're done, the drug is locked and into tox we go!



EUGENE SEYMOUR, MD, MPH
Chief Executive Officer
NANOVIRICIDES, INC
Nanotechnology-based targeted anti-viral therapeutics

http://www.nanoviricides.com
eugene@nanoviricides.com
310-486-5677

_____________________________________________________

Echo20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News